Business

FDA Review Timeline Extended for NUZ-001 IND Clinical Hold

FDA Review Timeline Extended for NUZ-001 IND Clinical Hold

Neurizon Therapeutics LimitedAugust 15, 20253
FDA Review Timeline Extended for NUZ-001 IND Clinical Hold

About this update from Neurizon Therapeutics Limited

Neurizon Therapeutics Limited has released a press release. View Attachment

View stock analysis, news, and events for Neurizon Therapeutics Limited

More from Neurizon Therapeutics Limited

All Neurizon Therapeutics Limited news →